Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

Introduction

This page provides a comprehensive analysis of the known insider trading history of Stephen M Dow. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Stephen M Dow has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ALDR / Alder BioPharmaceuticals, Inc. Director 307,190
10% Owner 0
US:CTXS / Citrix Systems, Inc. Director 23,869
US:CYTK / Cytokinetics, Incorporated Director 130,588
US:SPLK / Splunk Inc. 10% Owner 7,741
US:TNGO / Tangoe, Inc. 10% Owner 2,877,914
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Stephen M Dow. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CYTK / Cytokinetics, Incorporated - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CYTK / Cytokinetics, Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYTK / Cytokinetics, Incorporated Insider Trades
Insider Sales CYTK / Cytokinetics, Incorporated - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CYTK / Cytokinetics, Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2012-11-14 CYTK DOW STEPHEN M 1,742,950 0.6101 1,742,950 0.6101 1,063,374 7 3.75 5,472,690 514.65

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYTK / Cytokinetics, Incorporated Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Stephen M Dow as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2017-07-18 2017-07-18 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 25,000 307,190 8.86 10.00 250,000 3,071,900
2017-05-26 2017-05-24 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 15,000 15,000
2016-06-02 2016-05-26 4 ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 15,000 15,000
2015-12-02 2015-11-30 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -88 0 -100.00 37.11 -3,266
2015-11-18 2015-11-17 4 XCOM XTERA COMMUNICATIONS, INC.
Series E-3 Preferred Stock
C - Conversion -3,412,497 0 -100.00
2015-11-18 2015-11-17 4 XCOM XTERA COMMUNICATIONS, INC.
Series D-3 Preferred Stock
C - Conversion -3,496,724 0 -100.00
2015-11-18 2015-11-17 4 XCOM XTERA COMMUNICATIONS, INC.
Series C-3 Preferred Stock
C - Conversion -2,430,880 0 -100.00
2015-11-18 2015-11-17 4 XCOM XTERA COMMUNICATIONS, INC.
Series B-3 Preferred Stock
C - Conversion -28,898 0 -100.00
2015-11-18 2015-11-17 4 XCOM XTERA COMMUNICATIONS, INC.
Series A-3 Preferred Stock
C - Conversion -14,188,641 0 -100.00
2015-11-18 2015-11-17 4 XCOM XTERA COMMUNICATIONS, INC.
Common Stock
P - Purchase 200,000 1,210,984 19.78 5.00 1,000,000 6,054,920
2015-11-18 2015-11-17 4 XCOM XTERA COMMUNICATIONS, INC.
Common Stock
C - Conversion 1,010,984 1,010,984
2015-09-02 2015-08-31 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -16,218 282,278 -5.43 38.75 -628,460 10,938,498
2015-08-13 2015-08-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
J - Other 42 298,496 0.01
2015-08-13 2015-08-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
J - Other 8,110 298,454 2.79
2015-08-13 2015-08-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
J - Other -1,795,752 290,344 -86.08
2015-08-13 2015-08-12 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -97,109 2,086,096 -4.45 40.03 -3,887,409 83,509,343
2015-08-13 2015-08-11 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -115,358 2,183,205 -5.02 40.40 -4,660,763 88,207,158
2015-06-08 2015-06-04 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
J - Other 8,962 2,298,563 0.39
2015-06-03 2015-06-01 4 CTXS CITRIX SYSTEMS INC
Common Stock
A - Award 4,000 23,869 20.13
2015-05-21 2015-05-21 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale X -20,000 314,203 -5.98 65.69 -1,313,846 20,640,718
2015-05-21 2015-05-21 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale X -20,000 314,203 -5.98 65.69 -1,313,846 20,640,718
2015-05-21 2015-05-20 4/A ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
S - Sale -8,462 4,313,992 -0.20 40.39 -341,820 174,262,413
2015-05-21 2015-05-19 4/A ALDR ALDER BIOPHARMACEUTICALS INC
Stock Option (Right To Buy)
A - Award 6,350 6,350
2015-03-26 2015-03-25 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale X -38,936 334,203 -10.43 63.16 -2,459,198 21,108,261
2015-02-10 2014-12-08 5 CTXS CITRIX SYSTEMS INC
Common Stock
G - Gift -3,600 373,139 -0.96
2014-10-28 2014-10-27 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -1,505 0 -100.00
2014-10-28 2014-10-27 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 1,505 19,869 8.20 43.16 64,956 857,546
2014-10-28 2014-10-24 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -8,495 1,505 -84.95
2014-10-28 2014-10-24 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale X -8,495 18,364 -31.63 61.70 -524,142 1,133,059
2014-10-28 2014-10-24 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 8,495 26,859 46.26 43.16 366,644 1,159,234
2014-06-04 2014-06-02 4 CTXS CITRIX SYSTEMS INC
Common Stock
A - Award 4,000 18,364 27.85
2014-05-15 2014-05-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion 530,235 0 -100.00
2014-05-15 2014-05-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion 925,925 0 -100.00
2014-05-15 2014-05-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion 1,776,222 0 -100.00
2014-05-15 2014-05-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion 2,226,172 0 -100.00
2014-05-15 2014-05-13 4 ALDR ALDER BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 5,458,554 5,458,554
2014-04-29 2014-04-28 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise 2,364 0 -100.00
2014-04-29 2014-04-28 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 2,364 6,364 59.10 31.57 74,631 200,911
2014-04-29 2014-04-25 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise 7,636 2,364 -144.84
2014-04-29 2014-04-25 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale X -7,636 4,000 -65.62 60.50 -461,978 242,000
2014-04-29 2014-04-25 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 7,636 11,636 190.90 31.57 241,069 367,349
2013-06-05 2013-06-03 4 CTXS CITRIX SYSTEMS INC
Common Stock
A - Award 4,000 4,000
2013-03-18 2013-03-15 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -2,704 2,704 -50.00
2013-03-18 2013-03-15 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -7,075 7,075 -50.00
2013-03-18 2013-03-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 7,075 9,779 261.65 21.76 153,952 212,791
2013-03-18 2013-03-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 2,704 2,704 34.18 92,423 92,423
2013-03-18 2013-03-14 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -7,296 7,296 -50.00
2013-03-18 2013-03-14 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -12,925 12,925 -50.00
2013-03-18 2013-03-14 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale X -12,925 0 -100.00 74.60 -964,218
2013-03-18 2013-03-14 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 12,925 12,925 21.76 281,248 281,248
2013-03-18 2013-03-14 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale X -7,296 0 -100.00 74.59 -544,179
2013-03-18 2013-03-14 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 7,296 7,296 34.18 249,377 249,377
2013-01-04 2013-01-02 4 CYTK CYTOKINETICS INC
Stock Option (Right To Buy)
A - Award 130,588 130,588 0.27 35,011 35,011
2012-12-18 2012-12-14 4 CTXS CITRIX SYSTEMS INC
Common Stock
G - Gift -3,800 313,950 -1.20
2012-11-16 2012-11-14 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -1,742,950 1,421,052 -55.09 0.61 -1,063,374 866,984
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 7,741 7,741
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 7,741 7,741
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 14,008 14,008
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 7,741 7,741
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 11,895 11,895
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 16,050 16,050
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 8,505 8,505
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 271 271
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 59 59
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other 10,174 38,748 35.61
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other -114,000 164,961 -40.87
2012-10-18 2012-10-16 4 SPLK SPLUNK INC
Common Stock
J - Other -5,600,000 8,070,097 -40.97
2012-08-01 2012-08-01 4 SPLK SPLUNK INC
Common Stock
S - Sale -508,637 13,977,632 -3.51 27.26 -13,866,106 381,048,419
2012-07-25 2012-07-25 4 SPLK SPLUNK INC
Common Stock
S - Sale -1,945,363 14,486,269 -11.84 27.26 -53,033,124 394,914,525
2012-06-05 2012-06-01 4 CTXS CITRIX SYSTEMS INC
Common Stock
A - Award 4,000 61,010 7.02
2012-05-24 2012-05-22 4 CYTK CYTOKINETICS INC
Stock Option (Right To Buy)
A - Award 25,000 25,000
2012-04-24 2014-04-24 4 SPLK SPLUNK INC
Series B Preferred Stock
C - Conversion 3,981,286 0 -100.00
2012-04-24 2012-04-24 4 SPLK SPLUNK INC
Series C Preferred Stock
C - Conversion 2,232,478 0 -100.00
2012-04-24 2012-04-24 4 SPLK SPLUNK INC
Series A Preferred Stock
C - Conversion 10,000,000 0 -100.00
2012-04-24 2012-04-24 4 SPLK SPLUNK INC
Common Stock
C - Conversion 16,431,632 16,431,632
2012-04-18 3 SPLK SPLUNK INC
Common Stock
217,868
2012-02-21 2012-02-16 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -2,370 0 -100.00
2012-02-21 2012-02-16 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -29,157 0 -100.00
2012-02-21 2012-02-16 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise -4,818 0 -100.00
2012-02-21 2012-02-16 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 4,818 57,010 9.23 10.26 49,433 584,923
2012-02-21 2012-02-16 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 2,370 52,192 4.76 42.62 101,009 2,224,423
2012-02-21 2012-02-16 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 29,157 49,822 141.09 8.70 253,666 433,451
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise 30,843 36,180 577.91 8.70 268,334 314,766
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise 7,630 43,810 21.09 42.62 325,191 1,867,182
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Stock Option (Right To Buy)
M - Exercise 5,337 5,337 10.26 54,758 54,758
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale -5,337 0 -100.00 75.00 -400,275
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale -7,630 5,337 -58.84 75.00 -572,250 400,275
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
S - Sale -30,843 12,960 -70.41 75.00 -2,313,225 972,000
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 7,630 43,810 21.09 42.62 325,191 1,867,182
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 30,843 36,180 577.91 8.70 268,334 314,766
2012-02-17 2012-02-15 4 CTXS CITRIX SYSTEMS INC
Common Stock
M - Exercise 5,337 5,337 10.26 54,758 54,758
2012-02-01 2012-01-30 4 TNGO TANGOE INC
Common Stock
J - Other 253,481 2,877,914 9.66
2012-01-31 2012-01-29 4 TNGO TANGOE INC
Common Stock
J - Other 4,554 4,554
2012-01-31 2012-01-29 4 TNGO TANGOE INC
Common Stock
J - Other 17,148 17,148
2012-01-31 2012-01-29 4 TNGO TANGOE INC
Common Stock
J - Other 16 16
2012-01-31 2012-01-29 4 TNGO TANGOE INC
Common Stock
J - Other -874,807 2,624,433 -25.00
2012-01-05 2012-01-03 4 CYTK CYTOKINETICS INC
Stock Option (Right To Buy)
A - Award 51,020 51,020 0.39 20,000 20,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)